Other substances

Isorientin 4′-O-glucoside 2″-O-p-hydroxybenzoagte

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Natural product

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

Isorientin 4′-O-glucoside 2″-O-p-hydroxybenzoagte on PubChem

 

Structure image - Isorientin 4′-O-glucoside 2″-O-p-hydroxybenzoagte

C1=CC(=CC=C1C(=O)OC2[C@H]([C@@H](C(O[C@H]2C3=C(C4=C(C=C3O)OC(=CC4=O)C5=CC(=C(C=C5)O[C@H]6C([C@H]([C@@H](C(O6)CO)O)O)O)O)O)CO)O)O)O

Supporting references

Link Tested on Impact factor Notes Publication date
Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants – Withania somnifera (Ashwagandha), Tinospora cordifolia (Giloy) and Ocimum sanctum (Tulsi) – a molecular docking study
3CLpro Small molecule In silico 		in silico 3.22

Predicted to inhibit the SARS-CoV-2 3C-like protease.

 Aug/27/2020
Export (.csv)